MAPT and Alzheimer disease: Based on both CDI data and CSA measurements, we concluded that Sarkosyl-insoluble tau aggregates in human AD tau samples used in this study encompass a spectrum of distinct conformers within each individual sample and variable fraction of misfolded protease-sensitive tau.